Details of the SBP
General Information of Synthetic Binding Protein (SBP) (ID: SBP000290) | ||||||
---|---|---|---|---|---|---|
SBP Name |
Macrocyclic peptide anti-Integrin P5
|
|||||
Synonyms |
Macrocyclic peptide P5
|
|||||
Molecular Weight | 0.7 kDa | |||||
Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
Highest Status | Research | |||||
Sequence Length | 6 | |||||
SBP Sequence |
>Macrocyclic peptide anti-Integrin P5
RGD[d-Phe][N(Me)V] |
|||||
Sequence Description | Arg and Val form a bridge; [N(Me)V] represents N-methylated valine. | |||||
Protein Scaffold Information of This SBP | ||||||
---|---|---|---|---|---|---|
Scaffold ID | PS044 | [1] , [2] | ||||
Scaffold Name | Macrocyclic peptide | |||||
Scaffold Class | Non-Antibody | |||||
Fold Type | Beta-Sheets + Loops | |||||
Binding Target(s) of This SBP (BTS) |
---|
BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
---|---|---|---|---|---|---|
Integrin alpha-v-beta-3 | Antagonist | Cancers [ICD-11: 2D4Z] | N.A. | Massachusetts General Hospital | [1] , [2] | |
References |
---|